Lung cancer trials in Philippines

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  Pasig, Quezon City

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• Phase 2/3Taking people
  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  Where

  Bacolod City, Cebu City, Iloilo City, Makati City, Molo, Quezon City

  Age

  18 years and over

  People

  626 worldwide

  Run by

  Mirati Therapeutics Inc.

  See details and how to joinNCT04613596 · EU 2023-508922-83-00
• Phase 1Taking people
  Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

  Where

  Bacolod, Cebu City, City of Taguig, Davao City, Manila, Quezon City, San Juan City

  Age

  18 years and over

  People

  304 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT04686305 · EU 2023-504949-31-00